Everything
Spinal pain and post poliomyelitis syndrome - EM|consulte
Annals of Physical and Rehabilitation Medicine - Vol. 54 - N° S1 - p. e267-e268 - Spinal pain and post poliomyelitis syndrome - EM|consulte
ORIMUNE
Orimune Trademark details Orimune® is a registered trademark used for Poliomyelitis Vaccine and owned by American Cyanamid Company. Full trade mark registration details, registered images and more information below. View more » orimune Goods and/or Services:
doi:10.1016/S0140-6736(07)61077-0
Correspondence Submissions should be made via our electronic submission system at httpees.elsevier.com/ thelancet/ www.thelancet.com Vol 370 July 14, 2007 129 Protective efficacy of a monovalent oral type 1 poliovirus vaccine We are shocked and dismayed that The Lancet should have published the
Big programmes, big errors : The Lancet
Skip Main Navigation Click here! The Lancet RSS Feeds RSS Subscribe | Register | Login Close Username: Password: Forgotten Username or Password? Remember me on this computer until I logout Search for in All Fields Article Title, Abstract, Keywords Authors Article Title Abstract Advanced Search Home
Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin
RESEARCH ARTICLE Open Access Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in Germany Maren Eggers1* , Elena Terletskaia-Ladwig1 , Holger F Rabenau2 , Hans W Doerr 2 , Sabine Diedrich3 , Gisela Enders1 , Martin Enders1 Abstract
Discontinuation of Poliomyelitis Vaccine (Oral) Live — Irish Medical Times
February 4, 2012 Home Contact Us About Us Subscribe Advertising Terms of Use Privacy Policy Sitemap RSS Feeds Irish Medical Times News Opinion Features Editorial Letters Blogs Clinical Times MIMS Ireland Lifestyle Jobs Events Small ads You are here: Home / MIMS Ireland / Discontinued products /
doi:10.1016/S0140-6736(05)71284-8
For personal use only. Reproduce with permission from The Lancet Publishing Group. THE LANCET • Vol 357 • February 10, 2001 477 CORRESPONDENCE disasters could lead to a shortage of safe drinking water, exposure to infected water, or both. The poliovirus-seronegative population would certainly
doi:10.1016/S0140-6736(05)78658-X
1964 THE LANCET • Vol 351 • June 27, 1998 CORRESPONDENCE 1 Sheldon SH. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 1998; 351: 1254. 2 Dollins AB, Zhdanova IV, Wurtman RJ, Lynch HJ, Deng MH. Effect of inducing nocturnal serum melatonin concentrations in
doi:10.1016/S0140-6736(07)61080-0
Correspondence www.thelancet.com Vol 370 July 14, 2007 131 Author’s reply Contrary to Sunil Bahl and colleagues’ contention, I did not suggest that confirmed cases of polio and poliocompatible cases were the same thing. Poliomyelitis cases are confirmed only when poliovirus is identified in the
doi:10.1016/S0140-6736(05)78654-2
THE LANCET • Vol 351 • June 27, 1998 1963 CORRESPONDENCE Oral melatonin in neurologically disabled children Sir—Stephen Sheldon (April 25, p 1254)1 reports that daily oral administration of 5 mg or 1 mg melatonin to children with multiple neurological deficits results in increased seizure
Refine by Content Type:
Refine by Source:
- www.thelancet.com (94)
- download.thelancet.com (53)
- edoc.rki.de (3)
- healthcare.zibb.com (1)
- www.em-consulte.com (1)
- www.imt.ie (1)
